Some patients taking insurance denials to CEOs secure approvals by escalating disputes to insurer executives and leveraging AI-assisted appeals.

The TRIUMPH-2 and SYNCHRONIZE-2 studies show both novel agents to be highly effective, but some questions remain.

NEWBURYPORT, Mass. — This October, during Breast Cancer Awareness Month, Runway for Recovery is marking its 20th anniversary.

A large SEER-Medicare analysis found that after the 2016 CDC opioid guideline, prescribing and high-risk co-prescribing fell ...

First responders from American Medical Response who usually serve communities in Knox, Blount and McMinn counties are helping ...

A change to the login system for the MHS Genesis medical records' patient portal has caused headaches for military health ...

How Dangerous Is It and Who Is Most at Risk? / Bubonic Plague, Cancer Patients, cancer treatment, CDC, chemotherapy, ...

October is a big month at Adirondack Winery. The local business continues to raise money for the annual Making Strides walk ...

MSU's decision to wait 17 months to tell patients of sex assault allegations against Dr. Arpit Saxena was an institutional ...

Florida medical marijuana patients have received more than 17.21 billion milligrams of THC and 5.92 million ounces of ...

A pooled analysis of phase 3 ICONIC data demonstrates that concomitant GLP-1 medication use does not alter skin clearance, ...